BACKGROUND: Rapid on-site evaluation is a great tool for optimizing the adequacy and quality of cytologic samples. The objective of the current study was to analyze a low-cost telecytopathology method for the remote assessment of thyroid fine-needle aspiration biopsies (FNABs), with comparison of the primarily rendered adequacy and diagnosis with the final conventional analysis. METHODS: Material collected from thyroid FNABs was immediately smeared onto glass slides and stained with Diff-Quik. A conventional microscope attached to a smart device was operated on-site by either a medical student or a pathology resident for Wi-Fi transmission of the images by Skype. The cytopathologist would remotely guide the screening of the slides, zooming in and out of areas of interest. Remote assessment included an analysis of material adequacy and a preliminary diagnosis. The quality of the transmission and the number of slides also were recorded. After a washout period of 3 weeks, final diagnosis and adequacy were assigned by conventional microscopy. RESULTS: The final agreement rate for adequacy between remote and conventional analysis was 90.5%. For diagnosis, the final agreement rate was 83.3%. The diagnosis agreement rate varied, depending on the quality of transmission: there was 88% agreement when the quality was excellent, 77.8% agreement when it was good, and 62.5% agreement when it was poor.
INTRODUCTION
Telepathology has become a valuable tool in everyday pathology practice as technologies have evolved. 1 It can be used in different scenarios, from whole slide imaging (WSI) to the dynamic transmission of images for frozen consultation. [2] [3] [4] [5] Implementation of the technique is rapidly increasing worldwide, and the US Food and Drug Administration (FDA) recently approved the use of WSI for routine sign-out; however, it is still restricted to surgical pathology (histopathology). 6 Impediments to the wide acceptance of telepathology include its high cost and resistance to technologic advances by experienced pathologists. 7, 8 In cytopathology practice, a third factor involving the tridimensional nature of cytologic preparations may further hamper or delay its wide implementation.
cytopathologist's time is precious; and, with increasing caseloads and minimally invasive procedures, the dynamic transmission of slides rises as a useful strategy for the broad implantation of ROSE. 3, 5, 8, 15, 16 In thyroid fine-needle aspiration biopsy (FNAB), ROSE has significantly improved specimen adequacy, [11] [12] [13] 17 because it avoids undersampling scenarios and allows for the proper triage of materials for ancillary studies while also decreasing the mean number of needle passes, 14 reducing patient discomfort, and reducing the incidence of complications from the procedure. Published experiences with different systems indicate that telecytopathology is a valid alternative tool for the initial assessment and preliminary diagnosis of FNAB specimens with performance comparable to that of conventional ROSE. 3, 8, 15, 16, [18] [19] [20] [21] Nevertheless, the benefits of onsite assessment depend on trained personnel and adequate infrastructure, which are not always available in low-resource or remote centers. Recently, positive results have been reported from the evaluation of low-cost TC systems using portable devices and video calls through mobile phones, and such systems may contribute further to the broad implementation of transmission of dynamic images, especially in remote or lowresource scenarios. 8 The objective of the current study was to evaluate the use of a low-cost telecytopathology method based on a smart device allied to a free software application (Skype; Skype Technologies, Palo Alto, CA) that transmits realtime, live images for remote assessment of a prospective set of thyroid FNAs and to compare the adequacy and diagnosis primarily rendered by telecytopathology with the results from final conventional analysis.
MATERIALS AND METHODS
We prospectively evaluated consecutive thyroid FNABs performed in the ultrasound (US) suite with the aid of telecytopathology from January to June 2017. Patients were routinely received a free informed consent form minutes before their biopsies, which they had to read and consent if they wanted their samples to be included in the study, in accordance with approval by the local Research Ethics Board.
All FNABs were performed under US guidance in the radiology department using a Philips EnVisor Ultrasound system (Philips NV, Amsterdam, The Netherlands) with a linear, 12-MHz transducer. After the initial US evaluation, the indicated nodules were punctured with a 23-guge or 25-gauge needle attached to a 10-mL disposable plastic syringe.
Conventional smears were produced for each dedicated pass, air-dried, and subsequently stained with Diff-Quik in the same room at the time of the procedure.
A conventional microscope, with the aid of an adaptor for smart phone devices (SnapZoom; HI Resolution Enterprises, Honolulu, HI) attached to a sixth-generation iPodTouch (Apple Inc, Cupertino, CA) and an 8-megapixel rear Isight camera (Apple Inc), was operated on site by either a medical student or a pathology resident for Wi-Fi transmission (50 MB/second broadband network) of smear images over Skype (version 6.35.0.54 for iOS; Skype Technologies) (Fig. 1) to a remote, first-generation, 12.9-inch iPad Pro (Apple Inc) with a 2732 3 2048 retina display at 264 pixels per inch. A cytopathologist also remotely guided the screening of the slides by voice command over Skype, telling the operator to zoom in and out of areas of interest ( Fig. 2A,B) . Remote analyses included definition of specimen adequacy and preliminary diagnosis according to criteria established by the Bethesda System for Reporting Thyroid Cytopathology. 22 Patients who had aspirates that were deemed nondiagnostic (ND) at the time of the procedure were resampled, usually with a maximum of 3 needle passes for each thyroid nodule. The quality of transmission, the number of slides, and patient demographics also were recorded at the time of the procedure. Transmission quality was evaluated according to the clarity of voice commands through Skype, freezing/delay in image transmission, and clarity of the image. When all 3 parameters worked Figure 1 . This is the setup of the microscope and smart device (iPodTouch; Apple Inc, Cupertino, CA) used for the current study. The device was attached to microscope binoculars with an adaptor (SnapZoom; HI Resolution Enterprises, Honolulu, HI), and steady video transmission was then possible.
flawlessly, the remote cytopathologist would classify the transmission as excellent. Transmission quality was considered good when only 1 of the 3 parameters presented issues and poor when 2 or more parameters hampered a clear analysis of the images. After a washout period of 3 weeks, smears were reviewed by the same cytopathologist, and final specimen adequacy and final cytologic diagnosis were rendered for each smear. The concordance rate and j statistic between the on-site and final cytologic reports were calculated using the IBM SPSS Statistics software package (version 24.0; IBM Corporation, Armonk, NY).
RESULTS
In total, 42 thyroid FNAB specimens from 30 patients were included in this study. Patients were predominantly women (26 of 30 patients; 86.7%), and the median age was 49 years (age range, 27-86 years). The average number of slides per patient was calculated at 5 (range, 3-11 slides per case) ( Table 1) .
Agreement Between Preliminary and Final Adequacy and Diagnosis
On-site specimen adequacy was calculated as 14.3% (n 5 6) inadequate and 85.7% (n 5 36) adequate for analysis. In the final cytologic report, 4 specimens that initially were classified as ND were considered adequate, and final specimen adequacy was distributed as follows: 4.8% (n 5 2) inadequate and 95.2% (n 5 40) adequate for analysis. The final agreement rate for specimen adequacy between the preliminary and final analyses was calculated as 90.5% (38 of 42 specimens; j 5 0.461).
The preliminary diagnoses by TC were as follows: 14.3% (n 5 6) ND, 57.1% (n 5 24) benign, 14.3% (n 5 6) atypia of undetermined significance (AUS), 7.1% (n 5 3) follicular neoplasm or suspicious for follicular neoplasm (FN/SFN), 2.4% (n 5 1) suspicious for malignancy (SM), and 4.76% (n 5 2) malignant. Slides that had a discrepant diagnosis between the remote and conventional analyses, along with potential reasons for the observed discrepancy, are listed in Table 2 and include 4 cases that initially were diagnosed as ND and later reported as benign (n 5 2) and AUS (n 5 2); 2 preliminary benign results that eventually were classified as AUS; and 1 initially AUS case that was reclassified as benign in the final report. The final diagnostic agreement rate was calculated as 83.3% (j 5 0.685).
Transmission Quality and Final Agreement
The quality of transmission was deemed good or excellent in 34 cases (81%) and poor in 8 cases (19%). In cases with poor transmission, the preliminary diagnoses included 37.5% (n 5 3) ND nodules, 25% (n 5 2) benign, 25% (n 5 2) AUS, and 12.5% (n 5 1) SM. The final conventional diagnoses for these were ND in 12.5% of cases (n 5 1), whereas 50% (n 5 4) were classified as benign, 25% (n 5 2) were classified as AUS, and 12.5% (n 5 1) were classified as SM. The diagnostic agreement rate between preliminary and final diagnoses was calculated as 62.5% (j 5 0.500). For specimens in which transmission quality was classified as good, remote diagnoses comprised 20% (n 5 2) of ND results, 60% (n 5 6) of benign results, 10% (n 5 1) of AUS results, and 10% (n 5 1) of FN/SFN results. The final diagnoses were distributed as follows: 70% (n 5 7) benign, 20% (n 5 2) AUS, and 10% (n 5 1) FN/SFN. The diagnostic agreement rate between remote and final diagnoses was calculated as 77.8% (j 5 0.625).
For specimens in which transmission quality was classified as excellent, preliminary results comprised 4.2% 
DISCUSSION
The use of a low-cost telecytopathology system based on a smart device allied to a free software application for realtime, live transmission of images was an efficient method for remote assessment of thyroid FNAB adequacy and diagnosis, with high agreement rates between the remote and final evaluations. To the best of our knowledge, this is the largest prospective study to date on the use of a lowcost method for the remote assessment of thyroid FNABs.
In the current study, adequacy and diagnosis rendered by TC were highly concordant with the final cytology reports. Our results agree with previous reports in the literature, in which the initial assessment of thyroid aspiration biopsies using telecytopathology produced a diagnostic accuracy rate of up to 94% compared with the final cytology diagnoses. 3, 8, 15, 16, [18] [19] [20] 23 Reasons for discrepancies were mostly the paucity of diagnostic material. 3 Limitations of on-site assessment by telecytopathology are usually common to conventional ROSE and include interpretative challenges and an absence of Papanicolaou-stained slides and/or cell block material at the time of evaluation. 19 In addition, slides are rapidly scanned at the time of the procedure, and an adequacy check is the primary goal.
Our current results indicate that there was better agreement on final specimen adequacy than on final diagnosis. Thus, it is natural that the diagnosis may change in some cases. Indeed, all of our results that initially were deemed satisfactory but had a change in the final diagnosis compared with the preliminary report involved shifts from AUS to benign, or vice versa-a particularly complex dilemma in thyroid FNAB that usually requires a meticulous analysis of the slides, which is beyond the capability of rapid assessment. 22 We also noted an increase in nondiagnostic cases using virtual cytology, as previously reported, which also may be explained by the more rapid screening of smears. 23 These cases with low cellularity and/or occasional atypical cells would require a more detailed and time-consuming evaluation and may explain the discrepancies observed. 23 Differences in the level of cytopathology experience also may contribute to diagnostic discrepancies between on-site and final observers. 24 For example, less experienced professionals may be reluctant to make a definitive diagnosis of carcinoma. Similarly, inexperienced cytopathologists may use the indeterminate category in a higher percentage of cases. The interpretation of smears, as previously reported, 2,18,24 depends heavily on the individual who operates the slides, which also may contribute to discordant diagnoses. Transmission quality also can interfere with telecytopathology performance, as illustrated by our results. Agreement between primary and final diagnoses decreased consistently with reduced quality of transmission. However, the final results were similar to those obtained using high-cost technologies, 3, [18] [19] [20] [21] which may legitimize the use of our low-cost solution if special attention is paid to the quality of transmission. Image instability, however, may be more of an issue with unconventional, "simplified" systems, and attention must be drawn to this factor when low-cost technologies are implemented. Most reported experiences make use of high-definition digital cameras for image acquisition combined with direct Ethernet connections for live transmission and telephone data systems for verbal communication between the involved parties. 3, [18] [19] [20] [21] Depending on the systems used, overall costs for telecytopathology can range from US $5000 to $25,000, 7 an investment not always feasible in low-resource centers. In the current study, we tried to create an optimal TC system in light of the available resources at our service (a philanthropic hospital in Latin America). In this scenario, the use of a smart device (iPodTouch) in association with a free software application (Skype) was capable of sending fine live-video images and establishing a verbal connection with the remote viewer through a regular Wi-Fi connection at a reasonably low cost. In a similar approach, another series evaluated the use of smart phones and live FaceTime streaming (Apple Inc) for remote adequacy assessment of cytologic samples, with positive results. 8 In that study, 25 In addition, Skype can display the image being transmitted in a larger window than FaceTime, which facilitates guidance of the slide by the on-site operator. The future foresees an even greater use of smart phones for TC and telepathology solutions. Current devices are widely available and have built-in, high-resolution cameras that can work as alternatives for expensive, fixed, dedicated microscope cameras. In addition, these phones can connect to network systems through Wi-Fi and eliminate the need for a hardwired Ethernet connection. Portability also adds to the benefits of smart phones, bringing technology to remote centers. Disadvantages include the need for a stable server connection; issues in image focusing; and, as with other TC techniques, the requirement of a skilled slide driver. 7, 8 In the current study, we indeed have observed that the quality of transmission had a negative impact on the final agreement rate; and in remote or underdeveloped centers where server stability may be an issue, the use of these devices might be somewhat hampered. For choosing areas to examine and moving the slide, simple voice communication over video call technologies like as Skype proved to be efficient for proper screening of the most important areas of the slides: medical students and/or pathology residents operated our TC system with no significant difficulties. Another potential major disadvantage of the use of low-cost technologies is the issue of patient confidentiality. Images transmitted over the Internet with low-cost (not dedicated) technologies are not protected, and ethical/legal requirements may strengthen prerequisites for the implementation of such systems. Future solutions for assuring patient data safety when using these low-cost alternatives are needed to warrant their broad use. In the current study, only the study identification number was used during online communication, and no personal information was transmitted over Skype.
In conclusion, herein, we report the encouraging results from our experience with a low-cost telecytopathology technique. The use of a smart phone combined with a free software application for the real-time, live transmission of images was an efficient method for the remote
